Atossa Therapeutics, Inc. (ATOS) Earnings Call Transcripts

7 earnings calls from September 2020 to May 19, 2026

NasdaqCM US Health Care Biotechnology

About Atossa Therapeutics, Inc.

Atossa Therapeutics, Inc. (ATOS) is a publicly listed company in the Biotechnology industry, within the Health Care sector. It trades on NasdaqCM and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 7 calls on record spanning September 4, 2020 to May 19, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 7 Atossa Therapeutics, Inc. earnings call transcripts on record, spanning September 4, 2020 to May 19, 2026. Based on this history, Atossa Therapeutics, Inc. reports annually. The most recent call on file is dated May 19, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
ATOS
Exchange
NasdaqCM
Country
US
Sector
Health Care
Industry
Biotechnology
Calls on record
7
First call
September 4, 2020
Most recent
May 19, 2026
Reporting cadence
annually
Quarter Date
Special Calls May 19, 2026 Read transcript
Q4 FY2024 Mar 25, 2025 Read transcript
Q2 FY2023 Aug 14, 2023 Read transcript
Special Calls May 4, 2023 Read transcript
Special Calls Aug 25, 2022 Read transcript
Special Calls Nov 30, 2021 Read transcript
Company Conference Presentations Sep 4, 2020 Read transcript